活性成分
赋形剂
成分
纳米技术
生化工程
化学
药理学
材料科学
医学
工程类
食品科学
作者
Eva Hemmrich,Scott E. McNeil
标识
DOI:10.1038/s41565-023-01371-w
摘要
Nanomedicines are complex drugs where components that have typically been regarded as excipients may now be considered part of the active ingredient. The distinction between the active ingredient and excipients for nanomedicines has important consequences for regulatory review and product development. The dissimilarity in the review of the recent ribonucleic acid (RNA)-based lipid nanoparticles highlights the need for further regulatory alignment on this topic.
科研通智能强力驱动
Strongly Powered by AbleSci AI